Search for: "Julie Beitz" Results 1 - 7 of 7
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Oct 2023, 8:46 pm by Hyman Phelps McNamara
(“HP&M”), the largest FDA-dedicated law firm, is pleased to announce that Julie Beitz, M.D. has joined the firm as a Principal Drug Regulatory Expert. [read post]
25 Sep 2009, 1:30 pm
"This approval provides an alternative treatment for people with plaque psoriasis, which can cause significant physical discomfort from pain and itching and result in poor self-image for people who are self-conscious about their appearance," said Julie Beitz, M.D., director, Office of Drug Evaluation III, in the FDA's Center for Drug Evaluation and Research. [read post]
6 Mar 2012, 9:30 am by Lucas A. Ferrara, Esq.
"The approvals of Ultresa and Viokace, along with the other approved pancreatic enzyme products, allow health care providers to prescribe the product that is most appropriate for the estimated 200,000 patients in the United States who have pancreatic insufficiency," said Julie Beitz, M.D., director of the Office of Drug Evaluation III in FDA's Center for Drug Evaluation and Research. [read post]
6 Aug 2010, 10:00 am by Lucas A. Ferrara, Esq.
"Women using Evamist need to be aware of the potential risks to children who come in contact with the area of skin where this drug is applied," says Julie Beitz, M.D., a director of drug evaluation with FDA. [read post]
4 May 2012, 10:00 am by Lucas A. Ferrara, Esq.
"Today's approval provides for a new enzyme replacement therapy for the select number of patients with Type 1 Gaucher disease," said Julie Beitz, M.D., director of the Office of Drug Evaluation III in FDA's Center for Drug Evaluation and Research. [read post]
10 Sep 2014, 8:35 am
  See Larry Catá Backer, The Guiding Principles of Business and Human Rights at a Crossroads: The State, the Enterprise, and the Spectre of a Treaty to Bind them All (July 5, 2014). [read post]